{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T11:52:27Z","timestamp":1775303547341,"version":"3.50.1"},"reference-count":156,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2004,10,1]],"date-time":"2004-10-01T00:00:00Z","timestamp":1096588800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dermatologic Clinics"],"published-print":{"date-parts":[[2004,10]]},"DOI":"10.1016\/j.det.2004.03.010","type":"journal-article","created":{"date-parts":[[2005,4,18]],"date-time":"2005-04-18T14:53:34Z","timestamp":1113836014000},"page":"349-369","source":"Crossref","is-referenced-by-count":36,"title":["Current concepts in the immunopathogenesis of psoriasis"],"prefix":"10.1016","volume":"22","author":[{"given":"Michelle A.","family":"Lowes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wook","family":"Lew","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James G.","family":"Krueger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.det.2004.03.010_BIB1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1067\/mjd.2002.120568","article-title":"The immunologic basis for the treatment of psoriasis with new biologic agents","volume":"46","author":"Krueger","year":"2002","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.det.2004.03.010_BIB2","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/nm0595-442","article-title":"Response of psoriasis to a lymphocyte-selective toxin (DAB389IL-2) suggests a primary immune, but not keratinocyte, pathogenic basis","volume":"1","author":"Gottlieb","year":"1995","journal-title":"Nat Med"},{"issue":"5","key":"10.1016\/j.det.2004.03.010_BIB3","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1084\/jem.192.5.681","article-title":"Blockade of T lymphocyte costimulation with cytotoxic T lymphocyte-associated antigen 4-immunoglobulin (CTLA4Ig) reverses the cellular pathology of psoriatic plaques, including the activation of keratinocytes, dendritic cells, and endothelial cells","volume":"192","author":"Abrams","year":"2000","journal-title":"J Exp Med"},{"key":"10.1016\/j.det.2004.03.010_BIB4","series-title":"Fitzpatrick's dermatololgy in general medicine","first-page":"2457","article-title":"Immunobiologicals in dermatology","author":"Krueger","year":"2003"},{"issue":"2","key":"10.1016\/j.det.2004.03.010_BIB5","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1600-0560.1998.tb01694.x","article-title":"Intraepidermal lymphocytes in psoriatic lesions are activated GMP-17(TIA-1) + CD8 + CD3 + CTLs as determined by phenotypic analysis","volume":"25","author":"Austin","year":"1998","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.det.2004.03.010_BIB6","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1006\/jaut.1999.0343","article-title":"CD69, HLA-DR and the IL-2R identify persistently activated T cells in psoriasis vulgaris lesional skin: blood and skin comparisons by flow cytometry","volume":"14","author":"Ferenczi","year":"2000","journal-title":"J Autoimmun"},{"key":"10.1016\/j.det.2004.03.010_BIB7","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1038\/40166","article-title":"Cutaneous lymphocyte antigen is a specialized form of PSGL-1 expressed on skin-homing T cells","volume":"389","author":"Fuhlbrigge","year":"1997","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.det.2004.03.010_BIB8","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/labinvest.3780242","article-title":"Potential role of the chemokine receptors CXCR3, CCR4, and the integrin alphaEbeta7 in the pathogenesis of psoriasis vulgaris","volume":"81","author":"Rottman","year":"2001","journal-title":"Lab Invest"},{"key":"10.1016\/j.det.2004.03.010_BIB9","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1046\/j.0022-202x.2001.01481.x","article-title":"Role of integrin \u03b1E(CD103)\u03b27 for tissue-specific epidermal localization of CD8+ T lymphocytes","volume":"117","author":"Pauls","year":"2001","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.det.2004.03.010_BIB10","doi-asserted-by":"crossref","first-page":"9282","DOI":"10.1073\/pnas.91.20.9282","article-title":"CD8+ T cells in psoriatic lesions preferentially use T cell receptor V beta 3 and\/or V beta 13.1 genes","volume":"91","author":"Chang","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.det.2004.03.010_BIB11","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.1002\/(SICI)1521-4141(199910)29:10<3360::AID-IMMU3360>3.0.CO;2-G","article-title":"Selection of conserved TCR VDJ rearrangements in chronic plaque psoriatic plaques indicates a common antigen in psoriasis vulgaris","volume":"29","author":"Prinz","year":"1999","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.det.2004.03.010_BIB12","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1046\/j.0022-202x.2001.01548.x","article-title":"Oligoclonal expansion of intraepidermal T cells in psoriasis skin lesions","volume":"117","author":"Lin","year":"2001","journal-title":"J Invest Dermatol"},{"issue":"5","key":"10.1016\/j.det.2004.03.010_BIB13","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1046\/j.0022-202x.2001.01494.x","article-title":"Dominant lesional T cell receptor rearrangements persist in relapsing psoriasis but are absent from nonlesional skin: evidence for a stable antigen-specific pathogenic T cell response in psoriasis vulgaris","volume":"117","author":"Vollmer","year":"2001","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.det.2004.03.010_BIB14","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1002\/eji.1830240315","article-title":"T cell clones from psoriasis skin lesions can promote keratinocyte proliferation in vitro via secreted products","volume":"24","author":"Prinz","year":"1994","journal-title":"Eur J Immunol"},{"issue":"3","key":"10.1016\/j.det.2004.03.010_BIB15","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1034\/j.1600-0625.2001.010003168.x","article-title":"Epidermal CD8+ T cells in chronic plaque psoriasis are Tc1 cells producing heterogeneous levels of interferon-gamma","volume":"10","author":"Ovigne","year":"2001","journal-title":"Exp Dermatol"},{"issue":"5029","key":"10.1016\/j.det.2004.03.010_BIB16","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1126\/science.1681588","article-title":"Differing lymphokine profiles of functional subsets of human CD4 and CD8 T cell clones","volume":"254","author":"Salgame","year":"1991","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.det.2004.03.010_BIB17","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1046\/j.1523-1747.1999.00749.x","volume":"113","author":"Austin","year":"1999","journal-title":"J Invest Dermatol"},{"issue":"5","key":"10.1016\/j.det.2004.03.010_BIB18","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1111\/1523-1747.ep12371679","article-title":"The cytokine network in lesional and lesion-free psoriatic skin is characterized by a T-helper type 1 cell-mediated response","volume":"101","author":"Uyemura","year":"1993","journal-title":"J Invest Dermatol"},{"issue":"2","key":"10.1016\/j.det.2004.03.010_BIB19","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/1523-1747.ep12371752","article-title":"T cells involved in psoriasis vulgaris belong to the Th1 subset","volume":"102","author":"Schlaak","year":"1994","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.det.2004.03.010_BIB20","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1046\/j.1523-1747.1998.00446.x","article-title":"Expression of interleukin-12 is increased in psoriatic skin","volume":"111","author":"Yawalkar","year":"1998","journal-title":"J Invest Dermatol"},{"issue":"11","key":"10.1016\/j.det.2004.03.010_BIB21","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1172\/JCI6910","article-title":"Interleukin-11 therapy selectively downregulates type I cytokine proinflammatory pathways in psoriasis lesions","volume":"104","author":"Trepicchio","year":"1999","journal-title":"J Clin Invest"},{"key":"10.1016\/j.det.2004.03.010_BIB22","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1084\/jem.184.2.747","article-title":"Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation","volume":"184","author":"Cella","year":"1996","journal-title":"J Exp Med"},{"issue":"1\u20132","key":"10.1016\/j.det.2004.03.010_BIB23","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1615\/CritRevImmunol.v23.i12.50","article-title":"CD40 and dendritic cell function","volume":"23","author":"O'Sullivan","year":"2003","journal-title":"Crit Rev Immunol"},{"issue":"1","key":"10.1016\/j.det.2004.03.010_BIB24","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1471-2172-3-14","article-title":"Increased production of pro-inflammatory cytokines and enhanced T cell responses after activation of human dendritic cells with IL-1 and CD40 ligand","volume":"3","author":"Wesa","year":"2002","journal-title":"BMC Immunol"},{"issue":"1","key":"10.1016\/j.det.2004.03.010_BIB25","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1189\/jlb.0602326","article-title":"A unique role for IL-23 in promoting cellular immunity","volume":"73","author":"Lankford","year":"2003","journal-title":"J Leukoc Biol"},{"issue":"1","key":"10.1016\/j.det.2004.03.010_BIB26","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1152\/physiolgenomics.00157.2002","article-title":"Novel mechanisms of T-cell and dendritic cell activation revealed by profiling of psoriasis on the 63,100-element oligonucleotide array","volume":"13","author":"Zhou","year":"2003","journal-title":"Physiol Genomics"},{"issue":"Suppl","key":"10.1016\/j.det.2004.03.010_BIB27","doi-asserted-by":"crossref","first-page":"135S","DOI":"10.1111\/1523-1747.ep12876121","article-title":"Role of growth factors, cytokines, and their receptors in the pathogenesis of psoriasis","volume":"94","author":"Krueger","year":"1990","journal-title":"J Invest Dermatol"},{"issue":"10","key":"10.1016\/j.det.2004.03.010_BIB28","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1002\/eji.1830261009","article-title":"CD40 is functionally expressed on human keratinocytes","volume":"26","author":"Denfeld","year":"1996","journal-title":"Eur J Immunol"},{"issue":"6","key":"10.1016\/j.det.2004.03.010_BIB29","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/sj.gene.6364005","article-title":"Combinations of IFN-gamma and IL-4 induce distinct profiles of dendritic cell-associated immunoregulatory properties","volume":"4","author":"Banyer","year":"2003","journal-title":"Genes Immun"},{"issue":"21","key":"10.1016\/j.det.2004.03.010_BIB30","doi-asserted-by":"crossref","first-page":"4346","DOI":"10.1093\/nar\/25.21.4346","article-title":"Convergence of TNFalpha and IFNgamma signalling pathways through synergistic induction of IRF-1\/ISGF-2 is mediated by a composite GAS\/kappaB promoter element","volume":"25","author":"Pine","year":"1997","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"10.1016\/j.det.2004.03.010_BIB31","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/S0344-0338(11)80872-1","article-title":"Distribution of interferon-gamma receptors in normal and psoriatic skin","volume":"191","author":"van den Oord","year":"1995","journal-title":"Pathol Res Pract"},{"issue":"3","key":"10.1016\/j.det.2004.03.010_BIB32","first-page":"315","article-title":"Interferon gamma in keratinocytes in psoriasis","volume":"13","author":"McKenzie","year":"2003","journal-title":"Eur J Dermatol"},{"issue":"3","key":"10.1016\/j.det.2004.03.010_BIB33","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1001\/archderm.1990.01670270083013","article-title":"Psoriasis induced at the injection site of recombinant interferon gamma. Results of immunohistologic investigations","volume":"126","author":"Fierlbeck","year":"1990","journal-title":"Arch Dermatol"},{"issue":"2","key":"10.1016\/j.det.2004.03.010_BIB34","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1346-8138.1998.tb02364.x","article-title":"Psoriasis in a patient with immunoblastic lymphadenopathy (IBL)-like T cell lymphoma: a possible candidate of systemic release of interferon gamma","volume":"25","author":"Yamamoto","year":"1998","journal-title":"J Dermatol"},{"issue":"1","key":"10.1016\/j.det.2004.03.010_BIB35","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1056\/NEJM198607033150102","article-title":"Local and systemic effects of intradermal recombinant interferon-gamma in patients with lepromatous leprosy","volume":"315","author":"Nathan","year":"1986","journal-title":"N Engl J Med"},{"key":"10.1016\/j.det.2004.03.010_BIB36","series-title":"Abstracts from the 9th International Psoriasis Symposium","first-page":"86","article-title":"Treatment with humanized anti interferon gamma improves psoriatic lesions and down regulates multiple related genes","author":"Haider","year":"2003"},{"key":"10.1016\/j.det.2004.03.010_BIB37","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1146\/annurev.immunol.15.1.749","article-title":"Cellular responses to interferon-gamma","volume":"15","author":"Boehm","year":"1997","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.det.2004.03.010_BIB38","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1146\/annurev.immunol.19.1.623","article-title":"IRF family of transcription factors as regulators of host defense","volume":"19","author":"Taniguchi","year":"2001","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.det.2004.03.010_BIB39","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1126\/science.1071545","article-title":"A road map for those who don't know JAK-STAT","volume":"296","author":"Aaronson","year":"2002","journal-title":"Science"},{"issue":"6673","key":"10.1016\/j.det.2004.03.010_BIB40","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/32588","article-title":"Dendritic cells and the control of immunity","volume":"392","author":"Banchereau","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.det.2004.03.010_BIB41","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1046\/j.1523-1747.2002.19515.x","article-title":"Plasmacytoid dendritic cells: a new cutaneous dendritic cell subset with distinct role in inflammatory skin diseases","volume":"119","author":"Wollenberg","year":"2002","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.det.2004.03.010_BIB42","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/nri746","article-title":"Mouse and human dendritic cell subtypes","volume":"2","author":"Shortman","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.det.2004.03.010_BIB43","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s00403-002-0334-y","article-title":"Comparison of the distribution and numbers of antigen-presenting cells among T-lymphocyte-mediated dermatoses. CD1a+, factor X111a+, and CD68+ cells in excematous dermatitis, psoriasis, lichen planuse and graft-versus host disease","volume":"294","author":"Deguchi","year":"2002","journal-title":"Arch Dermatol Res"},{"issue":"11","key":"10.1016\/j.det.2004.03.010_BIB44","doi-asserted-by":"crossref","first-page":"6535","DOI":"10.4049\/jimmunol.151.11.6535","article-title":"Characterization of dermal dendritic cells obtained from normal human skin reveals phenotypic and functionally distinctive subsets","volume":"151","author":"Nestle","year":"1993","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.det.2004.03.010_BIB45","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1172\/JCI117308","article-title":"Characterization of dermal dendritic cells in psoriasis. Autostimulation of T lymphocytes and induction of Th1 type cytokines","volume":"94","author":"Nestle","year":"1994","journal-title":"J Clin Invest"},{"issue":"12","key":"10.1016\/j.det.2004.03.010_BIB46","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/BF02505293","article-title":"Immunohistochemical identification of type II alternatively activated dendritic macrophages (RM 3\/1 + 3, MS-1+\/\u2212, 25F9\u2212) in psoriatic dermis","volume":"288","author":"Djemadji-Oudjiel","year":"1996","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.det.2004.03.010_BIB47","doi-asserted-by":"crossref","first-page":"4507","DOI":"10.4049\/jimmunol.164.9.4507","article-title":"Development of Th1-inducing capacity in myeloid dendritic cells requires environmental instruction","volume":"164","author":"Vieira","year":"2000","journal-title":"J Immunol"},{"issue":"9","key":"10.1016\/j.det.2004.03.010_BIB48","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S0167-5699(97)01116-X","article-title":"Langerhans cells may trigger the psoriatic disease process via production of nitric oxide","volume":"18","author":"Morhenn","year":"1997","journal-title":"Immunol Today"},{"key":"10.1016\/j.det.2004.03.010_BIB49","series-title":"The immune system in health and disease","article-title":"Immunobiology","author":"Janeway","year":"2001"},{"issue":"1","key":"10.1016\/j.det.2004.03.010_BIB50","first-page":"25","article-title":"Biologic therapy for psoriasis: the tumor necrosis factor inhibitors infliximab and etanercept","volume":"71","author":"Weinberg","year":"2003","journal-title":"Cutis"},{"issue":"13","key":"10.1016\/j.det.2004.03.010_BIB51","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1038\/sj.onc.1206262","article-title":"Identification of NF-kappa B-regulated genes induced by TNFalpha utilizing expression profiling and RNA interference","volume":"22","author":"Zhou","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.det.2004.03.010_BIB52","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1146\/annurev.immunol.16.1.359","article-title":"NK cell receptors","volume":"16","author":"Lanier","year":"1998","journal-title":"Annu Rev Immunol"},{"issue":"1","key":"10.1016\/j.det.2004.03.010_BIB53","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0002-9440(10)65109-7","article-title":"Injection of pre-psoriatic skin with CD4+ T cells induces psoriasis","volume":"155","author":"Nickoloff","year":"1999","journal-title":"Am J Pathol"},{"issue":"8","key":"10.1016\/j.det.2004.03.010_BIB54","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s00403-002-0349-4","article-title":"Natural killer and natural killer-T cells in psoriasis","volume":"294","author":"Cameron","year":"2002","journal-title":"Arch Dermatol Res"},{"issue":"1","key":"10.1016\/j.det.2004.03.010_BIB55","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1046\/j.1365-2133.2003.05319.x","article-title":"Circulating natural killer cells in psoriasis","volume":"49","author":"Cameron","year":"2003","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.det.2004.03.010_BIB56","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1093\/intimm\/12.2.151","article-title":"IL-12 synergizes with IL-18 or IL-1 for IFN- production from human T cells","volume":"12","author":"Tominaga","year":"2000","journal-title":"Int Immunol"},{"issue":"2","key":"10.1016\/j.det.2004.03.010_BIB57","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/84264","article-title":"IL-18-stimulated GADD45\u03b2 required in cytokine-induced, but not TCR-induced, IFN-\u03b3","volume":"2","author":"Yang","year":"2001","journal-title":"Nat Immunol"},{"key":"10.1016\/j.det.2004.03.010_BIB58","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1046\/j.1523-1747.1999.00750.x","article-title":"Human keratinocytes constitutively express interleukin-18 and secrete biologically active interleukin-18 after treatment with pro-inflammatory mediators and dinitrochlorobenzene","volume":"113","author":"Naik","year":"1999","journal-title":"J Invest Dermatol"},{"issue":"11","key":"10.1016\/j.det.2004.03.010_BIB59","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/nri936","article-title":"Opinion: interpretation of the complexity of innate immune responses by functional genomics","volume":"2","author":"Ricciardi-Castagnoli","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.det.2004.03.010_BIB60","doi-asserted-by":"crossref","unstructured":"Wetzler L.M. The role of Toll-like receptor 2 in microbial disease and immunity. Vaccine 2003;21:S2\/55\u201360","DOI":"10.1016\/S0264-410X(03)00201-9"},{"key":"10.1016\/j.det.2004.03.010_BIB61","doi-asserted-by":"crossref","first-page":"32","DOI":"10.4049\/jimmunol.171.1.32","article-title":"Link between innate and adaptive immunity: Toll-like receptor 2 internalizes antigen for presentation to CD4+ T cells and could be an efficient vaccine target","volume":"171","author":"Schjetne","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.det.2004.03.010_BIB62","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1046\/j.1365-2133.2003.05287.x","article-title":"Normal keratinocytes express Toll-like receptors (TLRs) 1, 2 and 5: modulation of TLR expression in chronic psoriasis","volume":"148","author":"Baker","year":"2003","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.det.2004.03.010_BIB63","doi-asserted-by":"crossref","first-page":"178","DOI":"10.5858\/2003-127-178-IIRRIN","article-title":"Innate immune-related receptors in normal and psoriatic skin","volume":"127","author":"Curry","year":"2003","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.det.2004.03.010_BIB64","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1146\/annurev.immunol.20.100301.064801","article-title":"Interaction of heat shock proteins with peptides and antigen presenting cells: chaperoning of the innate and adaptive immune responses","volume":"20","author":"Srivastava","year":"2002","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.det.2004.03.010_BIB65","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1001\/archderm.135.9.1104","article-title":"The immunologic and genetic basis of psoriasis","volume":"135","author":"Nickoloff","year":"1999","journal-title":"Arch Dermatol"},{"issue":"2","key":"10.1016\/j.det.2004.03.010_BIB66","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/1523-1747.ep12334217","article-title":"Identification of aberrantly regulated genes in diseased skin using the cDNA differential display technique","volume":"108","author":"Rivas","year":"1997","journal-title":"J Invest Dermatol"},{"issue":"4","key":"10.1016\/j.det.2004.03.010_BIB67","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/sj.tpj.6500067","article-title":"Molecular classification of psoriasis disease-associated genes through pharmacogenomic expression profiling","volume":"1","author":"Oestreicher","year":"2001","journal-title":"Pharmacogenomics J"},{"issue":"1","key":"10.1016\/j.det.2004.03.010_BIB68","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/j.1365-2133.1997.tb03715.x","article-title":"Development of psoriasis after syngeneic bone marrow transplant from psoriatic donor: further evidence for adoptive autoimmunity","volume":"137","author":"Snowden","year":"1997","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.det.2004.03.010_BIB69","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/ajh.10169","article-title":"Resolution of psoriasis following allogeneic bone marrow transplantation for chronic myelogenous leukemia: case report and review of the literature","volume":"71","author":"Kanamori","year":"2002","journal-title":"Am J Hematol"},{"issue":"11","key":"10.1016\/j.det.2004.03.010_BIB70","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0167-5699(00)01735-7","article-title":"NKT cells: facts, functions and fallacies","volume":"21","author":"Godfrey","year":"2000","journal-title":"Immunol Today"},{"issue":"7","key":"10.1016\/j.det.2004.03.010_BIB71","doi-asserted-by":"crossref","first-page":"4076","DOI":"10.4049\/jimmunol.165.7.4076","article-title":"Overexpression of CD1d by keratinocytes in psoriasis and CD1d-dependent IFN-gamma production by NK-T cells","volume":"165","author":"Bonish","year":"2000","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.det.2004.03.010_BIB72","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1046\/j.0022-202x.2001.01458.x","article-title":"Cd1d is expressed on dermal dendritic cells and monocyte-derived dendritic cells","volume":"117","author":"Gerlini","year":"2001","journal-title":"J Invest Dermatol"},{"issue":"5","key":"10.1016\/j.det.2004.03.010_BIB73","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1084\/jem.20011908","article-title":"Distinct functional lineages of human V(alpha)24 natural killer T cells","volume":"195","author":"Lee","year":"2002","journal-title":"J Exp Med"},{"issue":"11","key":"10.1016\/j.det.2004.03.010_BIB74","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/S1471-4906(02)02323-2","article-title":"Distinct subsets of human Valpha24-invariant NKT cells: cytokine responses and chemokine receptor expression","volume":"23","author":"Kim","year":"2002","journal-title":"Trends Immunol"},{"issue":"2","key":"10.1016\/j.det.2004.03.010_BIB75","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0165-2478(02)00223-7","article-title":"NKT cell subsets in infection and inflammation","volume":"85","author":"Chan","year":"2003","journal-title":"Immunol Lett"},{"issue":"1","key":"10.1016\/j.det.2004.03.010_BIB76","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1046\/j.1365-2249.2002.01721.x","article-title":"CD3+ CD56+ NK T cells are significantly decreased in the peripheral blood of patients with psoriasis","volume":"127","author":"Koreck","year":"2002","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.det.2004.03.010_BIB77","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/S0923-1811(00)00120-1","article-title":"Characterization of a T cell line bearing natural killer receptors and capable of creating psoriasis in a SCID mouse model system","volume":"24","author":"Nickoloff","year":"2000","journal-title":"J Dermatol Sci"},{"issue":"4","key":"10.1016\/j.det.2004.03.010_BIB78","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/nri1054","article-title":"Organogenesis of lymphoid tissues","volume":"3","author":"Mebius","year":"2003","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"10.1016\/j.det.2004.03.010_BIB79","doi-asserted-by":"crossref","first-page":"424","DOI":"10.4049\/jimmunol.169.1.424","article-title":"Differing activities of homeostatic chemokines CCL19, CCL21, and CXCL12 in lymphocyte and dendritic cell recruitment and lymphoid neogenesis","volume":"169","author":"Luther","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.det.2004.03.010_BIB80","series-title":"Abstracts from the 9th International Psoriasis Symposium","first-page":"187","article-title":"Up-regulated expression of interleukin-20 in psoriasis is produced by monocytes and regulated in vivo by T-cells","author":"Wang","year":"2003"},{"issue":"1","key":"10.1016\/j.det.2004.03.010_BIB81","first-page":"257","article-title":"Differences in reactivity to cyclosporin A and interferon-gamma of normal and HPV-transformed keratinocytes","volume":"16","author":"Marionnet","year":"1996","journal-title":"Anticancer Res"},{"issue":"1","key":"10.1016\/j.det.2004.03.010_BIB82","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/1523-1747.ep12312542","article-title":"Keratinocyte-derived vascular permeability factor (vascular endothelial growth factor) is a potent mitogen for dermal microvascular endothelial cells","volume":"105","author":"Detmar","year":"1995","journal-title":"J Invest Dermatol"},{"issue":"9","key":"10.1016\/j.det.2004.03.010_BIB83","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S0167-5699(97)01116-X","article-title":"Langerhans cells may trigger the psoriatic disease process via production of nitric oxide","volume":"18","author":"Morhen","year":"1997","journal-title":"Immunol Today"},{"key":"10.1016\/j.det.2004.03.010_BIB84","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/1523-1747.ep12514689","article-title":"Localization of neutrophil-activating peptide-1\/interleukin 8-immunoreactivity in normal and psoriatic skin","volume":"96","author":"Sticherling","year":"1991","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.det.2004.03.010_BIB85","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1046\/j.1365-2133.2001.04178.x","article-title":"Severe combined immunodeficiency mouse-human skin chimeras: a unique animal model for the study of psoriasis and cutaneous inflammation","volume":"144","author":"Raychaudhuri","year":"2001","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.det.2004.03.010_BIB86","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1182\/blood-2002-12-3793","article-title":"Transgenic delivery of VEGF to mouse skin leads to an inflammatory condition resembling human psoriasis","volume":"102","author":"Xia","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.det.2004.03.010_BIB87","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S1074-7613(00)00064-9","article-title":"CD8+ T cell-mediated skin disease in mice lacking IRF-2, the transcriptional attenuator of interferon-\u03b1\/\u03b2 signaling","volume":"13","author":"Hida","year":"2000","journal-title":"Immunity"},{"issue":"1\u20132","key":"10.1016\/j.det.2004.03.010_BIB88","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1006\/geno.2001.6623","article-title":"Analysis of gene expression using high-density and IFN-gamma-specific low-density cDNA arrays","volume":"77","author":"Aberger","year":"2001","journal-title":"Genomics"},{"issue":"4","key":"10.1016\/j.det.2004.03.010_BIB89","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/1523-1747.ep12289702","article-title":"Transgenic mice expressing IFN-gamma in the epidermis have eczema, hair hypopigmentation, and hair loss","volume":"108","author":"Carroll","year":"1997","journal-title":"J Invest Dermatol"},{"issue":"1","key":"10.1016\/j.det.2004.03.010_BIB90","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1046\/j.1365-2249.1996.d01-802.x","article-title":"In vivo effects of cytokines on psoriatic skin grafted on nude mice: involvement of the tumour necrosis factor (TNF) receptor","volume":"106","author":"Gilhar","year":"1996","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.det.2004.03.010_BIB91","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/379777a0","article-title":"Pulling the trigger on psoriasis","volume":"379","author":"Boehncke","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.det.2004.03.010_BIB92","first-page":"580","article-title":"SCID mouse: human psoriatic skin chimeras\u2014validation of a new animal model","volume":"146","author":"Nickoloff","year":"1995","journal-title":"Am J Pathol"},{"issue":"8","key":"10.1016\/j.det.2004.03.010_BIB93","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1172\/JCI118989","article-title":"Dermal injection of immunocytes induces psoriasis","volume":"98","author":"Wrone-Smith","year":"1996","journal-title":"J Clin Invest"},{"issue":"12","key":"10.1016\/j.det.2004.03.010_BIB94","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/S1357-4310(98)01377-X","article-title":"Pathogenesis and immunointervention strategies for psoriasis. IBC's inflammatory skin disorders. Washington, DC, USA. September 17\u201318, 1998","volume":"4","author":"Nickoloff","year":"1998","journal-title":"Mol Med Today"},{"issue":"5","key":"10.1016\/j.det.2004.03.010_BIB95","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1001\/archderm.135.5.546","article-title":"Response of murine and normal human skin to injection of allogeneic blood-derived psoriatic immunocytes: detection of T cells expressing receptors typically present on natural killer cells, including CD94, CD158, and CD161","volume":"135","author":"Nickoloff","year":"1999","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.det.2004.03.010_BIB96","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/1523-1747.ep12335758","article-title":"T-lymphocyte dependence of psoriatic pathology in human psoriatic skin grafted to SCID mice","volume":"109","author":"Gilhar","year":"1997","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.det.2004.03.010_BIB97","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1046\/j.1523-1747.2002.01812.x","article-title":"Psoriasis is mediated by a cutaneous defect triggered by activated immunocytes: induction of psoriasis by cells with natural killer receptors","volume":"119","author":"Gilhar","year":"2002","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.det.2004.03.010_BIB98","first-page":"1047","article-title":"TNF-alpha-dependant induction of psoriasis in the absence of lymphocyte recruitment [abstract 24]","volume":"147","author":"Boyman","year":"2002","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.det.2004.03.010_BIB99","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1084\/jem.20031482","article-title":"Spontaneous development in a new animal model shows an essential role for resident T cells and tumor necrosis factor-\u03b1","volume":"5","author":"Boyman","year":"2004","journal-title":"J Exp Med"},{"issue":"17","key":"10.1016\/j.det.2004.03.010_BIB100","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1093\/hmg\/10.17.1793","article-title":"Insights into psoriasis and other inflammatory diseases from large-scale gene expression studies","volume":"10","author":"Bowcock","year":"2001","journal-title":"Hum Mol Genet"},{"issue":"3","key":"10.1016\/j.det.2004.03.010_BIB101","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1620\/tjem.161.159","article-title":"Decreased levels of IL-1 alpha and beta in psoriatic lesional skin","volume":"161","author":"Takematsu","year":"1990","journal-title":"Tohoku J Exp Med"},{"issue":"12","key":"10.1016\/j.det.2004.03.010_BIB102","doi-asserted-by":"crossref","first-page":"4593","DOI":"10.4049\/jimmunol.144.12.4593","article-title":"IL-1 activity is reduced in psoriatic skin. Decreased IL-1 alpha and increased nonfunctional IL-1 beta","volume":"144","author":"Cooper","year":"1990","journal-title":"J Immunol"},{"issue":"6","key":"10.1016\/j.det.2004.03.010_BIB103","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1002\/eji.1830250623","article-title":"Enhanced production of biologically active interleukin-1 alpha and interleukin-1 beta by psoriatic epidermal cells ex vivo: evidence of increased cytosolic interleukin-1 beta levels and facilitated interleukin-1 release","volume":"25","author":"Debets","year":"1995","journal-title":"Eur J Immunol"},{"issue":"4","key":"10.1016\/j.det.2004.03.010_BIB104","first-page":"133","article-title":"IL-1 alpha, IL-1 beta and psoriasis: conflicting results in the literature. Opposite behaviour of the two cytokines in lesional or non-lesional extracts of whole skin","volume":"11","author":"Bonifati","year":"1997","journal-title":"J Biol Regul Homeost Agents"},{"issue":"16","key":"10.1016\/j.det.2004.03.010_BIB105","doi-asserted-by":"crossref","first-page":"6367","DOI":"10.1073\/pnas.86.16.6367","article-title":"Interleukin 6 is expressed in high levels in psoriatic skin and stimulates proliferation of cultured human keratinocytes","volume":"86","author":"Grossman","year":"1989","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"10.1016\/j.det.2004.03.010_BIB106","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s004030050211","article-title":"Interleukin-11 production is increased in organ cultures of lesional skin of patients with active plaque-type psoriasis as compared with nonlesional and normal skin. Similarity to interleukin-1 beta, interleukin-6 and interleukin-8","volume":"289","author":"Ameglio","year":"1997","journal-title":"Arch Dermatol Res"},{"issue":"3","key":"10.1016\/j.det.2004.03.010_BIB107","first-page":"195","article-title":"Interleukin-6 in the epidermis of patients with psoriasis before and during PUVA treatment","volume":"69","author":"Oxholm","year":"1989","journal-title":"Acta Derm Venereol"},{"issue":"1","key":"10.1016\/j.det.2004.03.010_BIB108","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/1523-1747.ep12477880","article-title":"Increased IL-6 production by monocytes and keratinocytes in patients with psoriasis","volume":"97","author":"Neuner","year":"1991","journal-title":"J Invest Dermatol"},{"issue":"1","key":"10.1016\/j.det.2004.03.010_BIB109","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1006\/clin.1996.4313","article-title":"Increased interleukin-7 concentrations in lesional skin and in the sera of patients with plaque-type psoriasis","volume":"83","author":"Bonifati","year":"1997","journal-title":"Clin Immunol Immunopathol"},{"issue":"1","key":"10.1016\/j.det.2004.03.010_BIB110","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/BF02888047","article-title":"A study on the expression of interleukin (IL)-10 and IL-12 P35, P40 mRNA in the psoriatic lesions","volume":"21","author":"Cheng","year":"2001","journal-title":"J Tongji Med Univ"},{"issue":"4","key":"10.1016\/j.det.2004.03.010_BIB111","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.4049\/jimmunol.165.4.2240","article-title":"Inhibition of keratinocyte apoptosis by IL-15: a new parameter in the pathogenesis of psoriasis?","volume":"165","author":"Ruckert","year":"2000","journal-title":"J Immunol"},{"issue":"4","key":"10.1016\/j.det.2004.03.010_BIB112","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1046\/j.1523-1747.1998.00347.x","article-title":"Interleukin-17 and interferon-gamma synergize in the enhancement of proinflammatory cytokine production by human keratinocytes","volume":"111","author":"Teunissen","year":"1998","journal-title":"J Invest Dermatol"},{"issue":"7","key":"10.1016\/j.det.2004.03.010_BIB113","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1007\/s004030100240","article-title":"Expression of IL-18 in psoriasis","volume":"293","author":"Ohta","year":"2001","journal-title":"Arch Dermatol Res"},{"issue":"1","key":"10.1016\/j.det.2004.03.010_BIB114","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0092-8674(01)00187-8","article-title":"Interleukin 20: discovery, receptor identification, and role in epidermal function","volume":"104","author":"Blumberg","year":"2001","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.det.2004.03.010_BIB115","first-page":"129","article-title":"Cellular localization of interleukin-8 and its inducer, tumor necrosis factor-alpha in psoriasis","volume":"138","author":"Nickoloff","year":"1991","journal-title":"Am J Pathol"},{"issue":"1","key":"10.1016\/j.det.2004.03.010_BIB116","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/j.1365-2249.1994.tb06244.x","article-title":"Elevated tumour necrosis factor-alpha (TNF-alpha) biological activity in psoriatic skin lesions","volume":"96","author":"Ettehadi","year":"1994","journal-title":"Clin Exp Immunol"},{"issue":"12","key":"10.1016\/j.det.2004.03.010_BIB117","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1001\/archderm.1988.01670120051010","article-title":"Role of interferon-gamma in cutaneous trafficking of lymphocytes with emphasis on molecular and cellular adhesion events","volume":"124","author":"Nickoloff","year":"1988","journal-title":"Arch Dermatol"},{"issue":"6","key":"10.1016\/j.det.2004.03.010_BIB118","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1046\/j.1523-1747.1998.00419.x","article-title":"Identification and quantitation of interferon-gamma producing T cells in psoriatic lesions: localization to both CD4+ and CD8+ subsets","volume":"111","author":"Szabo","year":"1998","journal-title":"J Invest Dermatol"},{"issue":"6","key":"10.1016\/j.det.2004.03.010_BIB119","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1007\/BF00372087","article-title":"Detection of migration inhibitory factor (MIF) by a monoclonal antibody in the microvasculature of inflamed skin","volume":"282","author":"Gomez","year":"1990","journal-title":"Arch Dermatol Res"},{"issue":"6","key":"10.1016\/j.det.2004.03.010_BIB120","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1046\/j.1365-2133.1999.03206.x","article-title":"Evidence for a role of macrophage migration inhibitory factor in psoriatic skin disease","volume":"141","author":"Steinhoff","year":"1999","journal-title":"Br J Dermatol"},{"issue":"6","key":"10.1016\/j.det.2004.03.010_BIB121","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.4049\/jimmunol.158.6.2955","article-title":"The IL-1 system in psoriatic skin: IL-1 antagonist sphere of influence in lesional psoriatic epidermis","volume":"158","author":"Debets","year":"1997","journal-title":"J Immunol"},{"issue":"4","key":"10.1016\/j.det.2004.03.010_BIB122","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/j.1365-2133.1992.tb00446.x","article-title":"Distribution of interleukin 1 receptor antagonist protein (IRAP), interleukin 1 receptor, and interleukin 1 alpha in normal and psoriatic skin. Decreased expression of IRAP in psoriatic lesional epidermis","volume":"127","author":"Kristensen","year":"1992","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.det.2004.03.010_BIB123","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1172\/JCI115896","article-title":"Interleukin-1 receptor antagonist in normal and psoriatic epidermis","volume":"90","author":"Hammerberg","year":"1992","journal-title":"J Clin Invest"},{"issue":"10","key":"10.1016\/j.det.2004.03.010_BIB124","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1002\/eji.1830241018","article-title":"T lymphocytes derived from skin lesions of patients with psoriasis vulgaris express a novel cytokine pattern that is distinct from that of T helper type 1 and T helper type 2 cells","volume":"24","author":"Vollmer","year":"1994","journal-title":"Eur J Immunol"},{"issue":"1","key":"10.1016\/j.det.2004.03.010_BIB125","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1006\/clin.1994.1170","article-title":"Keratinocyte interleukin-10 expression is upregulated in tape-stripped skin, poison ivy dermatitis, and Sezary syndrome, but not in psoriatic plaques","volume":"73","author":"Nickoloff","year":"1994","journal-title":"Clin Immunol Immunopathol"},{"issue":"5","key":"10.1016\/j.det.2004.03.010_BIB126","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1046\/j.1523-1747.2002.19509.x","article-title":"Interleukin-13 receptor in psoriatic keratinocytes: overexpression of the mRNA and underexpression of the protein","volume":"119","author":"Cancino-Diaz","year":"2002","journal-title":"J Invest Dermatol"},{"issue":"1","key":"10.1016\/j.det.2004.03.010_BIB127","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/jcp.1041440119","article-title":"Transforming growth factor-beta 1 localization in normal and psoriatic epidermal keratinocytes in situ","volume":"144","author":"Kane","year":"1990","journal-title":"J Cell Physiol"},{"issue":"5","key":"10.1016\/j.det.2004.03.010_BIB128","doi-asserted-by":"crossref","first-page":"7S","DOI":"10.1111\/1523-1747.ep12505653","article-title":"Growth factor and proto-oncogene expression in psoriasis","volume":"95","author":"Elder","year":"1990","journal-title":"J Invest Dermatol"},{"issue":"3","key":"10.1016\/j.det.2004.03.010_BIB129","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/0923-1811(95)00438-6","article-title":"Differential localization of TGF-beta-precursor isotypes in psoriatic human skin","volume":"11","author":"Wataya-Kaneda","year":"1996","journal-title":"J Dermatol Sci"},{"issue":"1","key":"10.1016\/j.det.2004.03.010_BIB130","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1159\/000247852","article-title":"Granulocyte-macrophage colony-stimulating factor in psoriasis","volume":"181","author":"Takematsu","year":"1990","journal-title":"Dermatologica"},{"issue":"1\u20132","key":"10.1016\/j.det.2004.03.010_BIB131","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s004030050269","article-title":"Spontaneous release of leukemia inhibitory factor and oncostatin-M is increased in supernatants of short-term organ cultures from lesional psoriatic skin","volume":"290","author":"Bonifati","year":"1998","journal-title":"Arch Dermatol Res"},{"issue":"1","key":"10.1016\/j.det.2004.03.010_BIB132","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/1523-1747.ep12478128","article-title":"Upper keratinocytes of psoriatic skin lesions express high levels of NAP-1\/IL-8 mRNA in situ","volume":"97","author":"Gillitzer","year":"1991","journal-title":"J Invest Dermatol"},{"issue":"4","key":"10.1016\/j.det.2004.03.010_BIB133","first-page":"820","article-title":"Aberrant production of interleukin-8 and thrombospondin-1 by psoriatic keratinocytes mediates angiogenesis","volume":"144","author":"Nickoloff","year":"1994","journal-title":"Am J Pathol"},{"issue":"2","key":"10.1016\/j.det.2004.03.010_BIB134","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/j.1365-2249.1995.tb05525.x","article-title":"IL-8\/IL-8 receptor expression in psoriasis and the response to systemic tacrolimus (FK506) therapy","volume":"99","author":"Lemster","year":"1995","journal-title":"Clin Exp Immunol"},{"issue":"3","key":"10.1016\/j.det.2004.03.010_BIB135","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1111\/1523-1747.ep12343916","article-title":"Co-localized overexpression of GRO-alpha and IL-8 mRNA is restricted to the suprapapillary layers of psoriatic lesions","volume":"106","author":"Kulke","year":"1996","journal-title":"J Invest Dermatol"},{"issue":"5","key":"10.1016\/j.det.2004.03.010_BIB136","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1111\/1523-1747.ep12371803","article-title":"Differential expression of GRO-alpha and IL-8 mRNA in psoriasis: a model for neutrophil migration and accumulation in vivo","volume":"107","author":"Gillitzer","year":"1996","journal-title":"J Invest Dermatol"},{"issue":"6","key":"10.1016\/j.det.2004.03.010_BIB137","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1111\/1523-1747.ep12371692","article-title":"GRO-alpha mRNA is selectively overexpressed in psoriatic epidermis and is reduced by cyclosporin A in vivo, but not in cultured keratinocytes","volume":"101","author":"Kojima","year":"1993","journal-title":"J Invest Dermatol"},{"issue":"3","key":"10.1016\/j.det.2004.03.010_BIB138","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1084\/jem.168.3.941","article-title":"Detection of a gamma interferon-induced protein IP-10 in psoriatic plaques","volume":"168","author":"Gottlieb","year":"1988","journal-title":"J Exp Med"},{"issue":"1","key":"10.1016\/j.det.2004.03.010_BIB139","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/(SICI)1096-9896(199801)184:1<89::AID-PATH975>3.0.CO;2-Z","article-title":"The C-X-C chemokine Mig is highly expressed in the papillae of psoriatic lesions","volume":"184","author":"Goebeler","year":"1998","journal-title":"J Pathol"},{"issue":"12","key":"10.1016\/j.det.2004.03.010_BIB140","doi-asserted-by":"crossref","first-page":"6621","DOI":"10.4049\/jimmunol.164.12.6621","article-title":"Up-regulation of macrophage inflammatory protein-3 alpha\/CCL20 and CC chemokine receptor 6 in psoriasis","volume":"164","author":"Homey","year":"2000","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.det.2004.03.010_BIB141","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1046\/j.1365-2133.1998.02027.x","article-title":"RANTES expression in psoriatic skin, and regulation of RANTES and IL-8 production in cultured epidermal keratinocytes by active vitamin D3 (tacalcitol)","volume":"138","author":"Fukuoka","year":"1998","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.det.2004.03.010_BIB142","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/1523-1747.ep12363613","article-title":"MCP-1 mRNA expression in basal keratinocytes of psoriatic lesions","volume":"101","author":"Gillitzer","year":"1993","journal-title":"J Invest Dermatol"},{"issue":"2","key":"10.1016\/j.det.2004.03.010_BIB143","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/nm0202-157","article-title":"CCL27\u2013CCR10 interactions regulate T cell-mediated skin inflammation","volume":"8","author":"Homey","year":"2002","journal-title":"Nat Med"},{"issue":"2","key":"10.1016\/j.det.2004.03.010_BIB144","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1084\/jem.167.2.670","article-title":"Detection of transforming growth factor alpha in normal, malignant, and hyperproliferative human keratinocytes","volume":"167","author":"Gottlieb","year":"1988","journal-title":"J Exp Med"},{"issue":"4892","key":"10.1016\/j.det.2004.03.010_BIB145","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1126\/science.2916128","article-title":"Overexpression of transforming growth factor alpha in psoriatic epidermis","volume":"243","author":"Elder","year":"1989","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.det.2004.03.010_BIB146","doi-asserted-by":"crossref","first-page":"10S","DOI":"10.1111\/1523-1747.ep12505661","article-title":"Epidermal growth factor\/transforming growth factor alpha receptors and psoriasis","volume":"95","author":"King","year":"1990","journal-title":"J Invest Dermatol"},{"issue":"2","key":"10.1016\/j.det.2004.03.010_BIB147","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/00000372-199604000-00010","article-title":"Overexpression of amphiregulin, a major autocrine growth factor for cultured human keratinocytes, in hyperproliferative skin diseases","volume":"18","author":"Piepkorn","year":"1996","journal-title":"Am J Dermatopathol"},{"issue":"6","key":"10.1016\/j.det.2004.03.010_BIB148","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1111\/1523-1747.ep12476485","article-title":"Increased dermal expression of platelet-derived growth factor receptors in growth-activated skin wounds and psoriasis","volume":"96","author":"Krane","year":"1991","journal-title":"J Invest Dermatol"},{"issue":"4","key":"10.1016\/j.det.2004.03.010_BIB149","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1084\/jem.175.4.1081","article-title":"The insulin-like growth factor I receptor is overexpressed in psoriatic epidermis, but is differentially regulated from the epidermal growth factor receptor","volume":"175","author":"Krane","year":"1992","journal-title":"J Exp Med"},{"issue":"6","key":"10.1016\/j.det.2004.03.010_BIB150","first-page":"1619","article-title":"Altered expression of keratinocyte growth factor and its receptor in psoriasis","volume":"151","author":"Finch","year":"1997","journal-title":"Am J Pathol"},{"issue":"6","key":"10.1016\/j.det.2004.03.010_BIB151","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1111\/1523-1747.ep12326689","article-title":"Nerve growth factor is increased in psoriatic skin","volume":"105","author":"Fantini","year":"1995","journal-title":"J Invest Dermatol"},{"issue":"2","key":"10.1016\/j.det.2004.03.010_BIB152","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1080\/000155598433368","article-title":"Psoriatic keratinocytes express high levels of nerve growth factor","volume":"78","author":"Raychaudhuri","year":"1998","journal-title":"Acta Derm Venereol"},{"issue":"2","key":"10.1016\/j.det.2004.03.010_BIB153","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2340\/00015555738183","article-title":"Immunohistochemical localization of basic fibroblast growth factor in skin diseases","volume":"73","author":"Yaguchi","year":"1993","journal-title":"Acta Derm Venereol"},{"issue":"3","key":"10.1016\/j.det.2004.03.010_BIB154","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1084\/jem.180.3.1141","article-title":"Overexpression of vascular permeability factor\/vascular endothelial growth factor and its receptors in psoriasis","volume":"180","author":"Detmar","year":"1994","journal-title":"J Exp Med"},{"issue":"5","key":"10.1016\/j.det.2004.03.010_BIB155","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1046\/j.1523-1747.2001.01316.x","article-title":"Altered expression of angiopoietins and Tie2 endothelium receptor in psoriasis","volume":"116","author":"Kuroda","year":"2001","journal-title":"J Invest Dermatol"},{"issue":"1","key":"10.1016\/j.det.2004.03.010_BIB156","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1080\/00015559850135779","article-title":"Endothelin-1 levels are increased in sera and lesional skin extracts of psoriatic patients and correlate with disease severity","volume":"78","author":"Bonifati","year":"1998","journal-title":"Acta Derm Venereol"}],"container-title":["Dermatologic Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733863504000191?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733863504000191?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,1,24]],"date-time":"2024-01-24T23:30:55Z","timestamp":1706139055000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0733863504000191"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,10]]},"references-count":156,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2004,10]]}},"alternative-id":["S0733863504000191"],"URL":"https:\/\/doi.org\/10.1016\/j.det.2004.03.010","relation":{},"ISSN":["0733-8635"],"issn-type":[{"value":"0733-8635","type":"print"}],"subject":[],"published":{"date-parts":[[2004,10]]}}}